𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microglial precursors derived from mouse embryonic stem cells

✍ Scribed by Isabella Napoli; Katrin Kierdorf; Harald Neumann


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
561 KB
Volume
57
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Microglia are resident immune cells of the central nervous system. They can be directly isolated from the brain or from mixed postnatal glial cultures. Isolation of primary microglia is inefficient due to low yield. The cell line BV2 was used as a substitute for primary microglia, but BV2 are oncogenically transformed cells. Here, we established a protocol to generate microglial precursor lines from mouse embryonic stem (ES) cells. Microglial precursor cells were obtained from murine ES cells by differentiation of embryoid bodies to microglia within a mixed brain culture. Several independent ES cell‐derived microglial precursor (ESdM) lines were generated and characterized by flow cytometry, immunocytochemistry, and functional assays. All ESdM showed expression of IBa1, CD11b, CD45, F4/80, CD49d, and CD29, but were negative for cKit and CD34. Stimulation with interferon‐γ or lipopolysaccharide (LPS) demonstrated upregulation of proinflammatory cytokine gene transcription including nitric oxide synthase‐2, interleukin‐1β, and tumor necrosis factor‐α at levels comparable to primary microglia. The ESdM showed efficient and rapid phagocytosis of microsphere beads, which was increased after stimulation with LPS. ESdM expressed the chemokine receptor CX3CR1 and demonstrated directed migration toward the ligand CX3CL1. After in vivo transplantation into postnatal brain tissue, ESdM showed engraftment as cells with a microglial phenotype and morphology. Thus, ESdM are stable proliferating cells substantially having most characteristics of primary microglia and therefore being a suitable tool to study microglial function in vitro and in vivo. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Temporal expression changes during diffe
✍ Joon-Ik Ahn; Ki-Hwan Lee; Dong-Mi Shin; Jae-Won Shim; Chang-mee Kim; Hyun Kim; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 1 views

## Abstract Temporal analysis in gene expression during differentiation of neural stem cells (NSCs) was performed by using in‐house microarrays composed of 10,368 genes. The changes in mRNA level were measured during differentiation day 1, 2, 3, 6, 12, and 15. Out of 10,368 genes analyzed, 259 gene

Acellular matrices derived from differen
✍ Rekha Nair; Shreya Shukla; Todd C. McDevitt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 616 KB

## Abstract Embryonic stem cells (ESCs) can differentiate into all somatic cell types, thereby providing a robust cell source for regenerative medicine therapies. ESCs are commonly induced to differentiate via three‐dimensional cell aggregates called embryoid bodies (EBs), which recapitulate cellul

Insulin producing cells derived from emb
✍ Sudhanshu P. Raikwar; Nicholas Zavazava 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

## Abstract Derivation of insulin producing cells (IPCs) from embryonic stem (ES) cells provides a potentially innovative form of treatment for type 1 diabetes. Here, we discuss the current state of the art, unique challenges, and future directions on generating IPCs. J. Cell. Physiol. 218: 256–263

Expansion of mouse embryonic stem cells
✍ Elsa Abranches; Evguenia Bekman; Domingos Henrique; Joaquim M.S. Cabral 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

## Abstract Embryonic stem (ES) cells have been shown to differentiate in vitro into a wide variety of cell types having significant potential for tissue regeneration. Therefore, the operational conditions for the ex vivo expansion and differentiation should be optimized for large‐scale cultures. T